KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Gsk's Return on Capital Employed rose 300.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.05% for FY2024, which is 1300.0% down from last year.
  • Per Gsk's latest filing, its Return on Capital Employed stood at 0.12% for Q3 2025, which was up 300.0% from 0.09% recorded in Q2 2025.
  • Gsk's Return on Capital Employed's 5-year high stood at 0.26% during Q4 2023, with a 5-year trough of 0.05% in Q2 2022.
  • Its 5-year average for Return on Capital Employed is 0.11%, with a median of 0.11% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 1400bps in 2022, then crashed by -1800bps in 2024.
  • Over the past 5 years, Gsk's Return on Capital Employed (Quarter) stood at 0.08% in 2021, then soared by 180bps to 0.22% in 2022, then rose by 19bps to 0.26% in 2023, then plummeted by -70bps to 0.08% in 2024, then skyrocketed by 49bps to 0.12% in 2025.
  • Its Return on Capital Employed stands at 0.12% for Q3 2025, versus 0.09% for Q2 2025 and 0.09% for Q1 2025.